Skip to main content
Neurology and Therapy logoLink to Neurology and Therapy
. 2020 Feb 14;9(1):193–195. doi: 10.1007/s40120-020-00178-4

Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials

Angelo Ghezzi 1,, Tanuja Chitnis 2, Annik K-Laflamme 3, Rolf Meinert 4, Dieter A Häring 3, Daniela Pohl 5
PMCID: PMC7229072  PMID: 32060877

Correction to: Neurol Ther (2019) 8:461–475 10.1007/s40120-019-0146-z

Figures 1a, 1b and 3 were published incorrectly in the original version. The corrected images are given as follows.

graphic file with name 40120_2020_178_Fig1_HTML.jpg

Fig. 1 Kaplan–Meier estimates of time to 6 m-CDI (a) and 6 m-CDI+ (b) in young adult patients and the overall analysis population from pooled FREEDOMS/FREEDOMS II studies. The Cox regression model was adjusted for sex, age, baseline EDSS and number of relapses in the 2 years prior to the study. Subjects with baseline EDSS score < 2.0 were excluded for 6m-CDI. Subjects with baseline EDSS score ≤ 2.0 were excluded for 6m-CDI+ 6m-CDI 6-month confirmed disability improvement, 6m-CDI+ 6-month confirmed disability improvement-plus, CI confidence interval, EDSS Expanded Disability Status Scale, FTY fingolimod, HR hazard ratio

graphic file with name 40120_2020_178_Fig3_HTML.jpg

Fig. 3 Time to EDSS ≥ 4.0 in young adult patients and the overall analysis population from pooled FREEDOMS/FREEDOMS II studies. The Cox regression model was adjusted for sex, age, baseline EDSS and number of relapses in the 2 years prior to the study. Subjects with baseline EDSS score ≥ 4.0 were excluded. CI confidence interval, EDSS Expanded Disability Status Scale, FTY fingolimod, HR hazard ratio


Articles from Neurology and Therapy are provided here courtesy of Springer

RESOURCES